List of Tables
    Table 1. Chimeric Antigen Receptor Cell Therapy Market Opportunities & Trends in Global Market
    Table 2. Chimeric Antigen Receptor Cell Therapy Market Drivers in Global Market
    Table 3. Chimeric Antigen Receptor Cell Therapy Market Restraints in Global Market
    Table 4. Key Players of Chimeric Antigen Receptor Cell Therapy in Global Market
    Table 5. Top Chimeric Antigen Receptor Cell Therapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Chimeric Antigen Receptor Cell Therapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Chimeric Antigen Receptor Cell Therapy Product Type
    Table 9. List of Global Tier 1 Chimeric Antigen Receptor Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Chimeric Antigen Receptor Cell Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Chimeric Antigen Receptor Cell Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Chimeric Antigen Receptor Cell Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Chimeric Antigen Receptor Cell Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 30. Amgen Inc Corporate Summary
    Table 31. Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 32. Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 33. Autolus Therapeutics Plc Corporate Summary
    Table 34. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 35. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 36. Beijing Immunochina Medical Science & Technology Co Ltd Corporate Summary
    Table 37. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 38. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 39. Bellicum Pharmaceuticals Inc Corporate Summary
    Table 40. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 41. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 42. Bristol-Myers Squibb Co Corporate Summary
    Table 43. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 44. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 45. bluebird bio Inc Corporate Summary
    Table 46. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 47. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 48. CARsgen Therapeutics Ltd Corporate Summary
    Table 49. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 50. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 51. Celgene Corp Corporate Summary
    Table 52. Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 53. Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 54. Cell Medica Ltd Corporate Summary
    Table 55. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 56. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 57. Cellular Biomedicine Group Inc Corporate Summary
    Table 58. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 59. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 60. Celularity Inc Corporate Summary
    Table 61. Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 62. Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 63. Celyad SA Corporate Summary
    Table 64. Celyad SA Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 65. Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 66. Daiichi Sankyo Co Ltd Corporate Summary
    Table 67. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 68. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 69. Fosun Pharmaceutical AG Corporate Summary
    Table 70. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 71. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 72. Gilead Sciences Inc Corporate Summary
    Table 73. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 74. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 75. Guangzhou Anjie Biomedical Technology Co Ltd Corporate Summary
    Table 76. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 77. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 78. Hangzhou Converd Co Ltd Corporate Summary
    Table 79. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 80. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 81. Hebei Senlang Biotechnology Inc Ltd Corporate Summary
    Table 82. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 83. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 84. HRAIN Biotechnology Co Ltd Corporate Summary
    Table 85. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 86. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 87. Juno Therapeutics Inc Corporate Summary
    Table 88. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 89. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 90. Kite Pharma Inc Corporate Summary
    Table 91. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 92. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 93. Nanjing Legend Biotech Co Ltd Corporate Summary
    Table 94. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 95. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 96. NantKwest Inc Corporate Summary
    Table 97. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 98. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 99. Nkarta Inc Corporate Summary
    Table 100. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 101. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 102. Novartis AG Corporate Summary
    Table 103. Novartis AG Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 104. Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 105. Ono Pharmaceutical Co Ltd Corporate Summary
    Table 106. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 107. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 108. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Corporate Summary
    Table 109. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 110. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 111. Sorrento Therapeutics Inc Corporate Summary
    Table 112. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 113. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 114. Takara Bio Inc Corporate Summary
    Table 115. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Offerings
    Table 116. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Chimeric Antigen Receptor Cell Therapy Segment by Type in 2021
    Figure 2. Chimeric Antigen Receptor Cell Therapy Segment by Application in 2021
    Figure 3. Global Chimeric Antigen Receptor Cell Therapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Chimeric Antigen Receptor Cell Therapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Chimeric Antigen Receptor Cell Therapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Chimeric Antigen Receptor Cell Therapy Revenue in 2021
    Figure 8. By Type - Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Chimeric Antigen Receptor Cell Therapy Revenue Market Share, 2017-2028
    Figure 12. US Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Chimeric Antigen Receptor Cell Therapy Revenue Market Share, 2017-2028
    Figure 16. Germany Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Chimeric Antigen Receptor Cell Therapy Revenue Market Share, 2017-2028
    Figure 24. China Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Chimeric Antigen Receptor Cell Therapy Revenue Market Share, 2017-2028
    Figure 30. Brazil Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Chimeric Antigen Receptor Cell Therapy Revenue Market Share, 2017-2028
    Figure 33. Turkey Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Chimeric Antigen Receptor Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 37. Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 57. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 58. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 59. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 60. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 61. Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 62. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 63. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 64. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 65. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)